Capital World Investors - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 186 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital World Investors ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2020$10,211,000
-23.9%
213,1370.0%0.00%
-50.0%
Q1 2020$13,419,000
-49.2%
213,1370.0%0.00%
-33.3%
Q4 2019$26,412,000
+86.7%
213,1370.0%0.01%
+100.0%
Q3 2019$14,144,000
-16.6%
213,1370.0%0.00%
-25.0%
Q2 2019$16,959,000
-28.9%
213,1370.0%0.00%
-33.3%
Q1 2019$23,842,000
+11.0%
213,1370.0%0.01%0.0%
Q4 2018$21,482,000
-20.2%
213,1370.0%0.01%
-14.3%
Q3 2018$26,932,000
+50.6%
213,1370.0%0.01%
+75.0%
Q2 2018$17,884,000
-76.6%
213,137
-82.9%
0.00%
-76.5%
Q1 2018$76,578,000
+12.6%
1,244,759
+7.0%
0.02%
+13.3%
Q4 2017$67,987,000
-36.8%
1,163,759
-37.2%
0.02%
-37.5%
Q3 2017$107,604,000
-53.8%
1,853,959
-3.7%
0.02%
-56.4%
Q2 2017$233,115,000
+3.8%
1,925,459
-3.0%
0.06%
+1.9%
Q1 2017$224,499,000
-3.6%
1,984,959
-7.4%
0.05%
-8.5%
Q4 2016$232,778,000
-31.6%
2,142,459
+3.7%
0.06%
-33.0%
Q3 2016$340,201,000
+16.1%
2,066,959
+0.6%
0.09%
+11.4%
Q2 2016$293,059,000
+20.4%
2,053,959
+8.4%
0.08%
+17.9%
Q1 2016$243,317,000
+3.9%
1,893,959
+20.8%
0.07%
+3.1%
Q4 2015$234,112,000
+0.0%
1,567,537
+11.1%
0.06%
-5.8%
Q3 2015$234,018,000
+24.3%
1,410,937
+80.9%
0.07%
+35.3%
Q2 2015$188,276,000
-14.4%
780,0000.0%0.05%
-13.6%
Q1 2015$219,976,000
+180.4%
780,000
+55.1%
0.06%
+181.0%
Q4 2014$78,446,000
-55.0%
502,858
-31.8%
0.02%
-57.1%
Q3 2014$174,393,000
+0.0%
736,8000.0%0.05%
+2.1%
Q2 2014$174,349,000
-47.4%
736,800
-26.7%
0.05%
-48.9%
Q1 2014$331,357,000
+1677.9%
1,004,751
+272.1%
0.09%
+1466.7%
Q3 2013$18,638,000
+3.9%
270,000
-32.5%
0.01%0.0%
Q2 2013$17,936,000400,0000.01%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q3 2018
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders